Bausch Health Companies Inc.

NYSE:BHC

Drug Manufacturers - Specialty & Generic

Healthcare
$8.73 -2.21%

-$0.11 today

Market cap
$3.27B
Beta
0.41
P/E (TTM)
-1.5
EPS (TTM)
-$3.19
52W Low $4.57High $8.69

Volume 6.83M

Average 1.70M

BHC Retained Earnings

Cumulative profits kept in the business rather than paid out as dividends.

Bausch Health Companies Inc.NYSE: BHC

Retained Earnings · Q2 FY2026 · quarter ended Jun 2026

Retained earnings remains negative

Q2 FY2026 retained earnings was -$10.83B, compared with -$9.73B a year earlier.

Context

  • Retained earnings amounted to 43.7% of total assets at the end of Q2 FY2026, up 8.0 pp from a year earlier.
  • Retained earnings grew in size in 2 of the last 3 fiscal years.

What to watch

Whether retained earnings keeps falling in the next quarterly balance sheet after a -11.3% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterJun 2026
-$10.83B+2.3% QoQ
Last fiscal yearDec 2025
-$9.65B+1.8% YoY
Year agoJun 2025
-$9.73B-11.3% since
Retained Earnings past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-11.3%——
1 year+1.8%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Retained Earnings history

USD · from the balance sheet

Latest · FY2025
(9.65B) USD
Year-over-year change
+1.8%

Retained Earnings vs competitors

How BHC compares with its peers on the latest reported figures

  • BHC's Jun 2026 retained earnings of -$10.83B is the lowest of the 11 companies compared; the peer median is -$558.11M.
  • Its year-over-year change of -11.3% is the 7th highest of 11, against a peer median of -4.0%.
  • Retained earnings amounts to 43.7% of total assets for BHC, versus a peer median of 37.9%.
BHC Competitors Peer median
Retained Earnings for BHC and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
CPRXCatalyst Pharmaceuticals, Inc.Mar 2026$523.35M +53.1%+111.9%45.6%
HAEHaemonetics CorporationJun 2026$311.52M -12.5%+3.3%13.2%
CONConcentra Group Holdings Parent, Inc.Sep 2026$301.71M +151.3%-34.0%10.0%
ANIPANI Pharmaceuticals, Inc.Mar 2026$6.39M +107.5%—0.4%
HCMHUTCHMED (China) LimitedDec 2025-$378.64M +54.6%—21.6%
MLYSMineralys Therapeutics, Inc.Jun 2026-$737.58M -90.1%—110.4%
XRAYDENTSPLY SIRONA Inc.Mar 2026-$1.57B -85.6%—30.1%
BEAMBeam Therapeutics Inc.Jun 2026-$1.86B -4.5%—134.0%
ALVOAlvotechMar 2026-$2.41B -3.5%—169.5%
PRGOPerrigo Company plcJun 2026-$4B -76.5%—52.6%
BHCBausch Health Companies Inc.Jun 2026-$10.83B -11.3%—43.7%
Peer median (excluding BHC) -$558.11M-4.0%+3.3%37.9%

Competitors are the stored peer set for BHC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents582M564M947M1.18B1.32B
Short-term Investments00000
Net Receivables1.78B1.79B2B2.14B2.35B
Inventory993M1.09B1.54B1.6B1.63B
Other Current Assets1.54B39M1.11B858M850.45M
Total Current Assets5.61B4.25B5.6B5.77B6.15B
Property, Plant & Equipment (Net)1.6B1.6B1.71B1.78B2.07B
Goodwill12.46B11.55B11.18B11.09B11.25B
Intangible Assets6.95B5.8B6.46B5.55B4.63B
Long-term Investments00000
Tax Assets2.25B2.17B2.1B1.97B1.84B
Other Non-current Assets340M326M307M363M377.31M
Total Non-current Assets23.6B21.44B21.75B20.75B20.17B
Total Assets29.2B25.69B27.35B26.52B26.32B
Account Payables407M521M719M656M598.91M
Short-term Debt0432M450M2.67B296.46M
Tax Payables98M30M47M63M0
Deferred Revenue00000
Other Current Liabilities2.98B1.34B1.4B1.33B2.85B
Total Current Liabilities5.2B3.94B4.3B6.75B4.17B
Long-term Debt22.65B20.33B21.94B18.94B20.72B
Deferred Tax Liabilities529M202M163M128M146.73M
Deferred Revenue (Non-current)00000
Other Non-current Liabilities855M949M1.03B857.49M711.7M
Total Non-current Liabilities24.04B21.49B23.13B20.09B21.77B
Total Liabilities29.24B25.43B27.43B26.85B25.94B
Common Stock10.32B10.39B10.42B10.49B10.5B
Retained Earnings(8.96B)(9.19B)(9.78B)(9.82B)(9.65B)
Accumulated OCI(1.92B)(2.06B)(1.88B)(2.18B)(1.76B)
Other Stockholders Equity00000
Minority Interest72M952M940M957M929.31M
Total Equity(34M)260M(82M)(322M)376.31M
Total Debt22.65B20.77B22.39B21.83B21.21B
Net Debt22.07B20.2B21.44B20.65B19.88B

Bausch Health Companies Inc.

NYSE:BHC

Intrinsic Alpha fair value

Locked

Current Price

$8.73

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.